Oncology News and Research

RSS

Oncology, meaning bulk, mass, or tumor, and the suffix ''-logy'', meaning "study of") is a branch of medicine that deals with tumors (cancer). A medical professional who practices oncology is an ''oncologist''.

Zebrafish model reveals how BCG vaccine triggers immune response in bladder cancer

Using zebrafish "Avatars", an animal model developed by the Cancer Development and Innate Immune Evasion lab at the Champalimaud Foundation (CF), led by Rita Fior, Mayra Martínez-López – a former PhD student at the lab now working at the Universidad de las Américas in Quito, Ecuador – and colleagues studied the initial steps of the Bacillus Calmette-Guérin (BCG) vaccine's action on bladder cancer cells.

8 Aug 2024

The politics holding back Medicaid expansion in some Southern states

For Roderick Givens, a radiation oncologist, the expansion of Medicaid isn't just a policy issue. He practices medicine in a rural area in the Mississippi Delta and he sees daily how Medicaid coverage could help his uninsured patients.

8 Aug 2024

New method advances the creation of implantable human organs

Growing functional human organs outside the body is a long-sought "holy grail" of organ transplantation medicine that remains elusive.

7 Aug 2024

Radiotherapy after surgery shown to prevent breast cancer recurrence for up to 10 years

Providing radiotherapy after surgery could prevent breast cancer from returning in the same place for up to 10 years, a long-term study suggests.

7 Aug 2024

Study finds aspirin reduces colon cancer risk, with benefits varying by lifestyle factors

Aspirin can reduce colorectal cancer risk, but its effectiveness varies based on lifestyle factors such as diet, BMI, and smoking. Personalized recommendations are crucial to identify those who would benefit most from aspirin use.

7 Aug 2024

USC Norris to open state-of-the-art cancer center in Newport Beach with advanced radiation therapy

USC Norris Comprehensive Cancer Center, part of Keck Medicine of USC, will open a Newport Beach location offering the latest advancements in radiation therapy and diagnostic imaging.

7 Aug 2024

Decoding glioblastoma: New insights into molecular subtypes and mesenchymal transition mechanisms

Glioblastoma multiforme (GBM) stands as a formidable adversary in oncology, characterized by its molecular complexity and relentless progression.

7 Aug 2024

From discovery to approval: Vorasidenib approved by FDA for treatment of IDH-mutant gliomas

A new drug for treatment of a type of brain cancer, called IDH-mutant low-grade glioma, was approved Aug. 6 by the U.S. Food and Drug Administration (FDA).

7 Aug 2024

Small-town patients face big hurdles as rural hospitals cut cancer care

The night before her chemotherapy, Herlinda Sanchez sets out her clothes and checks that she has everything she needs: a blanket, medications, an iPad and chargers, a small Bible and rosary, fuzzy socks, and snacks for the road.

7 Aug 2024

Understanding the age gap in leukemia survival rates

Acute lymphoblastic leukemia (ALL) affects both children and adults, but children have better chances to be cured, with long-term survival rates over 85% compared to 50-75% in adults. Scientists at St. Jude Children's Research Hospital conducted a comprehensive study to understand the biological causes driving this difference. The work, published today in the Journal of Clinical Oncology, provides a blueprint for understanding B-cell acute lymphoblastic leukemia (B-ALL), the most common form of the disease.

7 Aug 2024

METRNL protein identified as key player in cancer progression

A protein called Meteorin-like (METRNL) in the tumor microenvironment saps energy from T cells, thereby severely limiting their ability to fight cancer, according to new research directed by investigators at the Johns Hopkins University School of Medicine and the Johns Hopkins Kimmel Cancer Center and its Bloomberg~Kimmel Institute for Cancer Immunotherapy. Finding ways to block the effects of METRNL signaling on tumor-infiltrating T cells may allow these immune cells to regain the energy necessary to eliminate tumors.

7 Aug 2024

Study highlights the need for language services in cancer trials

Underrepresentation of racial and ethnic minority populations in cancer clinical trials persists partly because translation and interpretation services and resources are unavailable or inadequate in the United States, according to a Children's Oncology Group (COG) study led by Columbia University School of Nursing. The updated study was published online in the Journal of the National Cancer Institute Cancer Spectrum on July 25, 2024, and will appear in the August 2024 journal issue.

7 Aug 2024

FDA approves vorasidenib for Grade 2 gliomas with IDH mutations

Vorasidenib has been approved by the U.S. Food and Drug Administration (FDA) for patients with Grade 2 gliomas with IDH1 or IDH2 mutations.

6 Aug 2024

Beckman Coulter Life Sciences and Illumina Accelerate Oncology Research with Launch of TruSight Oncology 500 DNA/RNA Application

...

From Beckman Coulter Life Sciences - Flow Cytometry 6 Aug 2024

INT-1B3 enhances anti-tumor immunity and prolongs survival in mouse models

A new research paper was published in Oncotarget's Volume 15 on July 12, 2024, entitled, "INT-1B3, an LNP formulated miR-193a-3p mimic, promotes anti-tumor immunity by enhancing T cell mediated immune responses via modulation of the tumor microenvironment and induction of immunogenic cell death."

5 Aug 2024

Renowned surgical oncologist takes leadership role at NYU Grossman Long Island School of Medicine

The Perlmutter Cancer Center at NYU Langone Hospital—Long Island has appointed Gary B. Deutsch, MD, MPH, a renowned and innovative surgical oncologist, as chief of NYU Grossman Long Island School of Medicine's Division of Surgical Oncology.

5 Aug 2024

Combining radiation with chemotherapy enhances survival in oligometastatic pancreatic cancer

Researchers from The University of Texas MD Anderson Cancer Center demonstrated that adding metastasis-directed radiation therapy to standard-of-care chemotherapy improved progression-free survival (PFS) in patients with oligometastatic pancreatic cancer.

5 Aug 2024

New study reveals hope for successful pregnancies post-allogeneic hematopoietic cell transplantation

Previous
1
...
92
93
94
95
96
97
98
...
1248
Next

Oncology News and Research

Further Reading

Zebrafish model reveals how BCG vaccine triggers immune response in bladder cancer

The politics holding back Medicaid expansion in some Southern states

New method advances the creation of implantable human organs

Radiotherapy after surgery shown to prevent breast cancer recurrence for up to 10 years

Study finds aspirin reduces colon cancer risk, with benefits varying by lifestyle factors

USC Norris to open state-of-the-art cancer center in Newport Beach with advanced radiation therapy

Decoding glioblastoma: New insights into molecular subtypes and mesenchymal transition mechanisms

From discovery to approval: Vorasidenib approved by FDA for treatment of IDH-mutant gliomas

Small-town patients face big hurdles as rural hospitals cut cancer care

Understanding the age gap in leukemia survival rates

METRNL protein identified as key player in cancer progression

Study highlights the need for language services in cancer trials

FDA approves vorasidenib for Grade 2 gliomas with IDH mutations

Beckman Coulter Life Sciences and Illumina Accelerate Oncology Research with Launch of TruSight Oncology 500 DNA/RNA Application

INT-1B3 enhances anti-tumor immunity and prolongs survival in mouse models

Renowned surgical oncologist takes leadership role at NYU Grossman Long Island School of Medicine

Combining radiation with chemotherapy enhances survival in oligometastatic pancreatic cancer

New study reveals hope for successful pregnancies post-allogeneic hematopoietic cell transplantation

Quality-of-life measurements are essential in cancer care, study says

Screening debate: Insufficient evidence to support lung cancer screening for non-smokers

Event guide: The 9th DDR Inhibitors Summit 2026 eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News